PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China.\', \'Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Israel.\', \'Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/cts.12880
?:doi
?:hasPublicationType
?:journal
  • Clinical and translational science
is ?:pmid of
?:pmid
?:pmid
  • 32881340
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.669
?:rankingScore_hIndex
  • 31
?:title
  • The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all